Method for producing natural killer cells
The use of rHSA and ascorbic acid in NK cell production enhances cell expansion and quality, addressing the scalability and efficiency issues of existing methods, resulting in higher yields and improved viability of NK cells for clinical use.
WO2026131850A1PCT designated stage Publication Date: 2026-06-25IPD THERAPEUTICS
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- IPD THERAPEUTICS
- Filing Date
- 2025-12-16
- Publication Date
- 2026-06-25
Smart Images
Figure 00000043_0000 
Figure 00000043_0001 
Figure 00000043_0002
Abstract
The present invention relates to a method for producing natural killer cells, a plurality of natural killer cells obtainable by a method for producing natural killer cells from hematopoietic stem cells, and a pharmaceutical composition comprising a plurality of natural killer cells obtainable by a method for producing natural killer cells from hematopoietic stem cells.
Need to check novelty before this filing date? Find Prior Art